EUVIMEDEUVIMED entdecken
Crossref

Sitagliptin protects renal ischemia reperfusion induced renal damage in diabetes

Jitendra Vaghasiya, Navin Sheth, Yagnik Bhalodia, Ravi Manek

Regulatory Peptides · 2011-01 · 166 (1-3) · 48-54

DOI: 10.1016/j.regpep.2010.08.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Regulatory Peptides, 2011-01. Verfasst von Jitendra Vaghasiya und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Jodhpur National University, Jodhpur, Rajasthan, India. j_vaghasiya@yahoo.com. Die Arbeit wurde bisher 86-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study was designed to investigate the possible effect of sitagliptin on renal damage induced by renal ischemia reperfusion (I/R) in diabetic rats. T2DM in rats was induced by the administration of nicotinamide (230 mg/kg, i.p.), 15 min prior to a single dose of streptozotocin (65 mg/kg, i.v.). In vivo renal I/R was performed in both T2DM and normal rats. Each protocol comprised ischemia for 30 min followed by reperfusion for 24h and a treatment period of 14 days before induction of ischemia. Sitagliptin treated diabetic rats that underwent renal I/R demonstrated significant decrease in the serum concentrations of aspartate aminotransferase (p < 0.01), urea nitrogen (p < 0.01) and creatinine (p < 0.001) compared to renal I/R in diabetic rats. Lipid peroxidation, xanthine oxidase activity, myeloperoxidase activity and nitric oxide level in renal tissue were significantly (p < 0.05, p < 0.001, p < 0.01, p < 0.05 respectively) decreased after renal I/R in sitagliptin treated rats compared to diabetic rats. Antioxidant enzymes like glutathione (p < 0.05), glutathione peroxidase (p < 0.001), superoxide dismutase (p < 0.05) and catalase (p < 0.001) were significantly increased after renal I/R in sitagliptin treated diabetic rats compared to non treated diabetic rats. The typical DNA laddering was observed when renal I/R performed in diabetic rats, which indicates cell apoptosis. Sitagliptin treated rats demonstrated a decrease in DNA fragmentation and apoptosis. Furthermore, renal histopathology preserved in sitagliptin treated rats verified protection against renal I/R in diabetes. The results of present investigation established sitagliptin treatment attenuated renal damage induced by renal I/R in diabetic rats.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsApoptosisCatalaseDNA FragmentationDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2FemaleGlutathioneGlutathione PeroxidaseKidneyKidney DiseasesLipid PeroxidationMaleOxidative StressPeroxidasePyrazinesRatsRats, WistarReperfusion InjurySitagliptin Phosphate

Substanzen

PyrazinesTriazolesCatalasePeroxidaseGlutathione PeroxidaseSuperoxide DismutaseXanthine OxidaseGlutathioneSitagliptin Phosphate

Autor:innen und Institutionen

  • Department of Pharmacology, Jodhpur National University, Jodhpur, Rajasthan, India. j_vaghasiya@yahoo.com

Zitieren

APA

Vaghasiya, J., Sheth, N., Bhalodia, Y., & Manek, R. (2011). Sitagliptin protects renal ischemia reperfusion induced renal damage in diabetes. Regulatory Peptides, 166(1-3), 48-54. https://doi.org/10.1016/j.regpep.2010.08.007

Vancouver

Vaghasiya J, Sheth N, Bhalodia Y, Manek R. Sitagliptin protects renal ischemia reperfusion induced renal damage in diabetes. Regulatory Peptides. 2011;166(1-3):48-54. doi:10.1016/j.regpep.2010.08.007

BibTeX
@article{Vaghasiya2011,
  author = {Vaghasiya, Jitendra and Sheth, Navin and Bhalodia, Yagnik and Manek, Ravi},
  title = {Sitagliptin protects renal ischemia reperfusion induced renal damage in diabetes},
  journal = {Regulatory Peptides},
  year = {2011},
  volume = {166},
  number = {1-3},
  pages = {48--54},
  doi = {10.1016/j.regpep.2010.08.007}
}
Kostenlos starten →